Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases
Chad G. Rusthoven(University of Colorado Cancer Center), Paul D. Brown(Mayo Clinic), Yasunori Sato(Keio University), Toru Serizawa(Osaka Neurological Institute), Atsuya Akabane(NTT Medical Center), Douglas Kondziolka(Neurological Surgery), Kename Nosaki(National Hospital Organization Kyushu Cancer Center), Brad E. Zacharia(Pennsylvania Department of Health), Benjamin Li(Vanderbilt University), Takashi Shuto(Yokohama Rosai Hospital), Leonard Tuanquin(Pennsylvania State University), Charles Touchette(Université de Sherbrooke), Andrew Faramand(University of Pittsburgh Medical Center), Christopher P. Cifarelli(West Virginia University), Justin C. Yuan(Beaumont Health), David Mathieu(Hôpital Fleurimont), Diogo Cordeiro(Neurological Surgery), Joshua D. Palmer(The Ohio State University), Hitoshi Aiyama(Hitachi (Japan)), Dexiang Gao(University of Colorado Cancer Center), Daniel Cagney(Mater Misericordiae University Hospital), Jason P. Sheehan(University of Virginia), Huai‐Che Yang(Taipei Veterans General Hospital), Masaaki Yamamoto(Hitachi (Japan)), Yoshinori Higuchi(Chiba University), Ayal A. Aizer(Brigham and Women's Hospital), Michael D. Chan(Wake Forest University), Derek Smith(University of Colorado Cancer Center), Ronald E. Warnick(Mercy Health), Veronica Chiang(Yale University), Samuel E. Day(University of Washington), L. Dade Lunsford(University of Pittsburgh), James B. Yu(Harvard University), Kenneth Bernstein(NYU Langone Health), Charu Singh(Yale University), Vivek Verma(Christ University), Denise Bernhardt(Heidelberg University), Steve Braunstein(University of California, San Francisco), Lia M. Halasz(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Joshua S. Silverman(NYU Langone Health), James McInerney(Penn State Milton S. Hershey Medical Center), Z.A. Siddiqui(Beaumont Health), Shoji Yomo(Aizawa Hospital), Daniel M. Trifiletti(Mayo Clinic in Florida), Cheng‐Chia Lee(Taipei Veterans General Hospital), Albert Attia(Vanderbilt University), Christopher P. Deibert(Emory University), T. Seto(National Hospital Organization Kyushu Cancer Center), Inga S. Grills(Beaumont Health), Ajay Niranjan(University of Pittsburgh)
Cited by 220
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
|Journal of Clinical Oncology|2011|1.4k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
|Journal of Clinical Oncology|2013|1.1k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k